Nature’s Exclusive Brand Acquires over 134,000 New Customers in 2020

Cannabis Investing News
CSE:TBI

Thoughtful Brands Inc. (CSE:TBI)(FWB:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands”), a global natural health products and eCommerce technology company, is proud to announce that its United States-based CBD brand Nature’s Exclusive acquired 134,861 new customers in the year 2020 to date.

Thoughtful Brands Inc. (CSE:TBI)(FWB:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands”), a global natural health products and eCommerce technology company, is proud to announce that its United States-based CBD brand Nature’s Exclusive acquired 134,861 new customers in the year 2020 to date.

The Company attributes the strong sales performance of its Nature’s Exclusive brand to the addition of innovative products and significant investment in customer acquisition.

Building off the success of Nature’s Exclusive, Thoughtful Brands is continuing to expand its portfolio in the nutraceutical and hemp-based CBD product space through the August 2020 acquisitions of Golden Path LLC and Wild Mariposa LLC, two direct-to-consumer eCommerce brands offering natural health products throughout the U.S. The Company expects to leverage its recently acquired eCommerce platform to ramp up customer acquisition and sales of its newly acquired brands.

“By investing in our established brands and forging agreements to sell new brands through our recently acquired eCommerce sales platform, we are charging ahead with our goal to be the global leader in the natural health products industry. With our drive and experience, we are excited to make quality CBD products more accessible than ever before to both experienced and new consumers. We look forward to an even stronger fourth quarter across our brands” said Thoughtful Brands CEO, Ryan Dean Hoggan.

About Thoughtful Brands

Thoughtful Brands is an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe. Through continuous strategic acquisitions, the Company has a strong footprint in the CBD market, as well as the burgeoning psychedelic medicine sector. Thoughtful Brands owns and operates a 110,000 square foot pharmaceutical manufacturing facility in Radebeul, Germany, where its highly skilled team conducts clinical studies utilizing naturally occurring psilocybin and other compounds found in psychedelics for the treatment of opiate addiction, while planning for future opportunities to create proprietary psilocybin products.

ON BEHALF OF THE BOARD OF DIRECTORS

THOUGHTFUL BRANDS INC.
Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at info@thoughtful-brands.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including with respect to its plans to the ability to leverage its recently acquired eCommerce platform to ramp up customer acquisition and sales of its newly acquired brands, ability to make CBD products more accessible. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

Source

The Conversation (0)
×